Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Cash from Financing Activities (2016 - 2026)

Mimedx's Cash from Financing Activities history spans 16 years, with the latest figure at -$2.6 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 10.18% to -$2.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$5.1 million, a 41.8% decrease, with the full-year FY2025 number at -$5.4 million, up 84.17% from a year prior.
  • Cash from Financing Activities hit -$2.6 million in Q1 2026 for Mimedx, down from -$583000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for MDXG hit a ceiling of $370000.0 in Q3 2023 and a floor of -$33.5 million in Q1 2024.
  • Historically, Cash from Financing Activities has averaged -$3.0 million across 5 years, with a median of -$400000.0 in 2024.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 200.0% in 2022 and later tumbled 836575.0% in 2024.
  • Tracing MDXG's Cash from Financing Activities over 5 years: stood at $66000.0 in 2022, then crashed by 13645.45% to -$8.9 million in 2023, then soared by 95.53% to -$400000.0 in 2024, then tumbled by 45.75% to -$583000.0 in 2025, then tumbled by 343.4% to -$2.6 million in 2026.
  • Business Quant data shows Cash from Financing Activities for MDXG at -$2.6 million in Q1 2026, -$583000.0 in Q4 2025, and -$857000.0 in Q3 2025.